Literature DB >> 11943202

Accelerated alpha-synuclein fibrillation in crowded milieu.

Vladimir N Uversky1, Elisa M Cooper, Kiowa S Bower, Jie Li, Anthony L Fink.   

Abstract

Parkinson's disease is the second most common age-related neurodegenerative disease, resulting from loss of dopaminergic neurons in the substantia nigra. The aggregation and fibrillation of alpha-synuclein has been implicated as a causative factor in the disease, and the process of fibril formation has been intensively studied in vitro with dilute protein solutions. However, the intracellular environment of proteins is crowded with other macromolecules, whose concentration can reach 400 g/l. To address this discrepancy, the effect of molecular crowding on alpha-synuclein fibrillation has being studied. The addition of high concentrations of different polymers (proteins, polysaccharides and polyethylene glycols) dramatically accelerated alpha-synuclein fibrillation in vitro. The magnitude of the accelerating effect depended on the nature of the polymer, its length and concentration. Our results suggest that the major factor responsible for the accelerated fibrillation under crowded conditions is the excluded volume.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11943202     DOI: 10.1016/s0014-5793(02)02446-8

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  80 in total

1.  Competition between protein folding and aggregation with molecular chaperones in crowded solutions: insight from mesoscopic simulations.

Authors:  Akira R Kinjo; Shoji Takada
Journal:  Biophys J       Date:  2003-12       Impact factor: 4.033

2.  Life in a crowded world.

Authors:  Germán Rivas; Frank Ferrone; Judith Herzfeld
Journal:  EMBO Rep       Date:  2004-01       Impact factor: 8.807

3.  Generalized fundamental measure theory for atomistic modeling of macromolecular crowding.

Authors:  Sanbo Qin; Huan-Xiang Zhou
Journal:  Phys Rev E Stat Nonlin Soft Matter Phys       Date:  2010-03-26

Review 4.  Drug targets from genetics: α-synuclein.

Authors:  Karin M Danzer; Pamela J McLean
Journal:  CNS Neurol Disord Drug Targets       Date:  2011-09-01       Impact factor: 4.388

5.  Insoluble alpha-synuclein in Alzheimer's disease without Lewy body formation.

Authors:  Melissa Broe; Claire E Shepherd; David M A Mann; Elizabeth A Milward; Wei-Ping Gai; Emma Thiel; Glenda M Halliday
Journal:  Neurotox Res       Date:  2005       Impact factor: 3.911

6.  A model of intracellular organization.

Authors:  Gary J Pielak
Journal:  Proc Natl Acad Sci U S A       Date:  2005-04-19       Impact factor: 11.205

7.  Backbone assignment and dynamics of human α-synuclein in viscous 2 M glucose solution.

Authors:  Kuen-Phon Wu; Jean Baum
Journal:  Biomol NMR Assign       Date:  2010-09-25       Impact factor: 0.746

8.  Concerted action of metals and macromolecular crowding on the fibrillation of alpha-synuclein.

Authors:  Larissa A Munishkina; Anthony L Fink; Vladimir N Uversky
Journal:  Protein Pept Lett       Date:  2008       Impact factor: 1.890

9.  Guiding protein aggregation with macromolecular crowding.

Authors:  Larissa A Munishkina; Atta Ahmad; Anthony L Fink; Vladimir N Uversky
Journal:  Biochemistry       Date:  2008-07-30       Impact factor: 3.162

Review 10.  Neurobiology of alpha-synuclein.

Authors:  Kostas Vekrellis; Hardy J Rideout; Leonidas Stefanis
Journal:  Mol Neurobiol       Date:  2004-08       Impact factor: 5.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.